Tags: Grifols

Summary of Grifols, S.A. (GRFS) | Monday May 8, 2017 Grifols, S.A. (NASDAQ:GRFS), from Healthcare sector has been on the upside of the performance spectrum. Grifols, S.A. stated a price of 21.28 today, indicating a positive change of -0.51%. Grifols, S.A. is operating with a market capitalization of 14.61B, with a return on assets (ROA) of *TBA and an…

THE QUANTITATIVE RELATIONSHIPS Grifols, S.A. (GRFS), started its day with an opening price of 21.36 as the company saw a change of -2.02%. The Average Volume of the business is currently 642 with a P/E (price to earnings) ratio of 50.99 , while Forward P/E ratio is 17.03. The price to earnings ratio specifies the…

Overview: Grifols, S.A. (NASDAQ:GRFS), from Healthcare sector has been doing well recently. Grifols, S.A. has been operating with a total market capitalizations of 14.97 B and has reported a price of 21.92 today, highlighting a positive change of 0.97%. The average volume stands at 631.94 for Grifols, S.A.. Performance: The performance week for Grifols, S.A.…

Brief Overview Grifols, S.A. (NASDAQ:GRFS), from Healthcare sector has been performing well. Grifols, S.A. reported a price of 21.71 today, indicating a change of 2.55%. Grifols, S.A. has a market capitalization of 14824.11, with a return on assets (ROA) of *TBA and an earnings per share (EPS) of 0.43 for the current year The gross…

Grifols, S.A. (NASDAQ: GRFS) | Friday April 28, 2068 With a market cap of 14455.38, Grifols, S.A. (NASDAQ:GRFS) has a large market cap size. Grifols, S.A. (NASDAQ: GRFS) has been on the stock market since its IPO date on the 06/02/2011. Grifols, S.A. is in the Biotechnology industry and Healthcare sector. Average volume for Grifols, S.A., is 627.08, and…

With its market value over its outstanding shares, Grifols, S.A. (NASDAQ:GRFS) Biotechnology has a market capitalization valued at Biotechnology. As the outstanding stock of Grifols, S.A. NASDAQ:GRFS Biotechnology is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of Grifols, S.A. GRFS Biotechnology. The existing figure surely determines the key factor…

Brief Overview Grifols, S.A. (NASDAQ:GRFS), from Healthcare sector has been performing well. Grifols, S.A. reported a price of 20.61 today, indicating a change of 1.73%. Grifols, S.A. has a market capitalization of 14073, with a return on assets (ROA) of *TBA and an earnings per share (EPS) of 0.43 for the current year The gross…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Grifols, S.A. (NASDAQ:GRFS) Biotechnology is valued at 13622.34. The dominant statistics will authorize the investment community to govern the size of Grifols, S.A. compared to the sales or total assets figures. Consequently, investors will be able to grasp the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Grifols, S.A. (NASDAQ:GRFS) Biotechnology is valued at 13533.57. The dominant statistics will authorize the investment community to govern the size of Grifols, S.A. compared to the sales or total assets figures. Consequently, investors will be able to grasp the…

Brief Overview Grifols, S.A. (NASDAQ:GRFS), from Healthcare sector has been performing well. Grifols, S.A. reported a price of 19.82 today, indicating a change of 0.00%. Grifols, S.A. has a market capitalization of 13533.57, with a return on assets (ROA) of *TBA and an earnings per share (EPS) of 0.43 for the current year The gross…